Bigfoot Biomedical lands $45M as it readies first diabetes product
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
From California to Boston to NYC, four more life science startups have been accepted into the Thiel Foundation's Breakout Labs, a philanthropic incubator for seed-stage companies.